Zeta CD71 Antibody. Zeta’s rabbit recombinant monoclonal antibody recognizes CD71, a ~90-95kDa protein identified as cell surface transferrin receptor (CD71), a disulfide-bonded homodimeric glycoprotein of 180-190kDa (Workshop IV). Zeta’s antibody to CD71 is highly specific to CD71 and shows no cross-reaction with other related proteins. The ligand for CD71, the transferrin receptor, is the serum iron transport protein, transferrin. The CD71 receptor is broadly distributed in carcinomas, sarcomas, leukemias, and lymphomas. CD71/Transferrin Receptor has been reported to be associated with cell proliferation in both normal and neoplastic tissues and helpful in predicting clinical behavior or response to therapy in several malignancies, including breast cancer.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.